GH vs. LH: Guardant Health vs. Labcorp Stock Comparison
How do Guardant Health (GH) and Labcorp (LH) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Guardant Health (GH) and Labcorp (LH) are both classified in the Health Care Services sub-industry within the broader Health Care Providers & Services industry, placing them in the closest GICS peer bucket.
| Profile Item | GH | LH |
|---|---|---|
| Name | Guardant Health, Inc. | Labcorp Holdings Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Services | Health Care Services |
| Market Capitalization | 20.41 billion USD | 29.77 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | October 4, 2018 | March 29, 1990 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | GH | LH |
|---|---|---|
| Total Return (1Y) | 66.53% | 48.62% |
| Total Return (3Y, Annualized) | 92.76% | 23.39% |
| Total Return (5Y, Annualized) | 8.36% | 10.54% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | GH | LH |
|---|---|---|
| Volatility (1Y, Annualized) | 53.23% | 24.36% |
| Beta (5Y) | 1.69 | 0.85 |
| Max Drawdown (5Y) | -85.09% | -34.61% |
| Avg. Volume (3M) | 1.97M | 721.05K |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | GH | LH |
|---|---|---|
| Sharpe Ratio (1Y) | 1.17 | 1.82 |
| Sortino Ratio (1Y) | 1.84 | 2.99 |
Profitability
ROE (TTM)
Capital efficiency shows on one side only: Labcorp (LH) earns 11.44% on shareholders’ equity, ranked against its industry; Guardant Health (GH) has no ROE this period.
GH
Health Care Equipment & Services industry group
--
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
- GH
- --
LH
Health Care Equipment & Services industry group
11.44%
- Max
- 47.61%
- Q3
- 14.36%
- LH
- 11.44%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Guardant Health (GH) reports a negative net margin of -37.93%, usually indicating a net loss over the period. Meanwhile Labcorp (LH) reports 6.88%, ranking against industry peers normally.
GH
Health Care Equipment & Services industry group
-37.93%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
- GH
- -37.93%
LH
Health Care Equipment & Services industry group
6.88%
- Max
- 29.35%
- Q3
- 9.33%
- LH
- 6.88%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Guardant Health (GH) reports a negative operating margin of -37.06%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Labcorp (LH) reports 10.91%, ranking against industry peers normally.
GH
Health Care Equipment & Services industry group
-37.06%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
- GH
- -37.06%
LH
Health Care Equipment & Services industry group
10.91%
- Max
- 35.43%
- Q3
- 14.14%
- LH
- 10.91%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | GH | LH |
|---|---|---|
| ROE (TTM) | -- | 11.44% |
| ROA (TTM) | -19.92% | 5.48% |
| Net Margin (TTM) | -37.93% | 6.88% |
| Operating Margin (TTM) | -37.06% | 10.91% |
| Gross Margin (TTM) | 65.19% | 28.96% |
Growth
Revenue Growth
Guardant Health (GH) at 32.88% sits in the top revenue growth quartile, while Labcorp (LH) at 7.25% is closer to the peer norm — faster top-line expansion for GH.
EPS Growth
Only one side can be read here: Labcorp (LH) reports EPS growth of 18.33%, ranked against its industry; Guardant Health (GH) has no EPS growth figure this period.
Growth Metrics
| Metric | GH | LH |
|---|---|---|
| Revenue Growth (YoY) | 32.88% | 7.25% |
| Revenue Growth (3Y CAGR) | 29.75% | 5.55% |
| EPS Growth (YoY) | -- | 18.33% |
| EPS Growth (3Y CAGR) | -- | -9.19% |
Financial Strength
Current Ratio (MRQ)
Both Guardant Health (GH) at 3.60 and Labcorp (LH) at 1.41 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
GH
Health Care Equipment & Services industry group
3.60
- Max
- 7.59
- Q3
- 4.00
- GH
- 3.60
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
LH
Health Care Equipment & Services industry group
1.41
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- LH
- 1.41
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Only one side’s leverage can be read here: Labcorp (LH) carries debt-to-equity ratio of 0.77 against its industry range, while Guardant Health (GH) reports no figure this period.
GH
Health Care Equipment & Services industry group
--
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
- GH
- --
LH
Health Care Equipment & Services industry group
0.77
- Max
- 1.88
- Q3
- 0.91
- LH
- 0.77
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | GH | LH |
|---|---|---|
| Current Ratio (MRQ) | 3.60 | 1.41 |
| Debt / Equity (MRQ) | -- | 0.77 |
| Net Debt / EBITDA | -- | 2.81 |
Dividends
Dividend Yield (TTM)
Guardant Health (GH) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Labcorp (LH) reports a yield of 0.79%, ranking against industry peers normally.
GH
Health Care Equipment & Services industry group
0.00%
- GH
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LH
Health Care Equipment & Services industry group
0.79%
- LH
- 0.79%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Guardant Health (GH) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Labcorp (LH) reports a payout of 23.61%, ranking against industry peers normally.
GH
Health Care Equipment & Services industry group
0.00%
- GH
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LH
Health Care Equipment & Services industry group
23.61%
- LH
- 23.61%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | GH | LH |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.79% |
| Dividend Payout Ratio (TTM) | 0.00% | 23.61% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: Labcorp (LH) trades at 30.05 times trailing earnings, ranked against its peers, while Guardant Health (GH) has no P/E ratio this period.
GH
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- GH
- --
LH
Health Care Equipment & Services industry group
30.05
- Max
- 80.41
- Q3
- 47.62
- LH
- 30.05
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Labcorp (LH) at 2.04 prices around its industry’s typical P/S ratio, while Guardant Health (GH) at 15.96 clears its benchmark range — GH looks notably rich on sales.
GH
Health Care Equipment & Services industry group
15.96
- GH
- 15.96
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
LH
Health Care Equipment & Services industry group
2.04
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- LH
- 2.04
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Guardant Health (GH) reports a negative P/B ratio of -73.67, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Labcorp (LH) reports 3.36, ranking against industry peers normally.
GH
Health Care Equipment & Services industry group
-73.67
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
- GH
- -73.67
LH
Health Care Equipment & Services industry group
3.36
- Max
- 11.68
- Q3
- 6.12
- LH
- 3.36
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | GH | LH |
|---|---|---|
| P/E Ratio (TTM) | -- | 30.05 |
| P/S Ratio (TTM) | 15.96 | 2.04 |
| P/B Ratio (MRQ) | -73.67 | 3.36 |
| Free Cash Flow Yield (TTM) | -0.30% | 3.55% |